Research progress of nasolacrimal duct stent implantation to improve prognosis
- Author:
- No author available
- Journal Title:
- Journal of Chinese Ophthalmology and Otorhinolaryngology
- Issue:
- 2
- DOI:
- 10.3969/j.issn.1674-9006.2024.02.012
- Key Word:
- 鼻泪管阻塞性疾病;泪道支架;泪囊鼻腔吻合术;Nasolacrimal duct obstructive disease;Lacrimal duct stent;Dacryocystorhinostomy
Abstract： Primary nasolacrimal duct obstruction typically presents as persistent tearing,which can lead to seconda-ry conditions such as keratitis,acute or chronic dacryocystitis,affecting ocular health.Nasolacrimal duct stenting is often an important adjunctive method for treating this condition,effectively reducing the postoperative membrane-related recur-rence rates of lacrimal duct probing,laser dacryoplasty,and lacrimal sac-nasal duct anastomosis.However,issues such as mechanical damage,persistent chronic inflammation post-surgery,and scar tissue formation still contribute to postopera-tive nasal lacrimal duct narrowing and re-obstruction.The article provides a comprehensive review of the pathogenesis of recurrent obstruction in nasolacrimal duct stenting and the corresponding advanced measures for improvement,offering new perspectives for clinical diagnosis and treatment.
- [1]杨伟,马鸿娟,哈少平.泪道支架术后再次梗阻280眼原因探析[J].2017,(12).
- [2]李一鸣,周学义,张历浊,等.5-Fu对鼻泪道阻塞人工鼻泪管支架逆行置入术疗效的影响[J].2018,(8).
- [3]潘泽军,黄蓉.庆大霉素、地塞米松联合鼻内窥镜引导下泪道硅胶管逆行植入术治疗鼻泪管阻塞疗效观察[J].2020,(4).
- [4]M J, Walland,G E, Rose.Factors affecting the success rate of open lacrimal surgery.[J].1994,78(12).
- [5]Jae, Murphy,Mohammed Javed, Ali,Alkis James, Psaltis.Biofilm Quantification on Nasolacrimal Silastic Stents After Dacryocystorhinostomy.[J].1900,31(5).
- [6]Lee-Wing MW,Ashenhurst ME.Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.[J].2001,108(11).
- [7]Kosuke Ueda,Akihide Watanabe,Norihiko Yokoi,etc.Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy[J].2019,38(1).
- [8]顾国强.羊膜泪道修复支架植入治疗泪道阻塞性疾病效果观察[J].2022,29(6).
- [9].Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease.[J].2017,12(6).
- [10]Kim KR,Song HY,Shin JH,etc.Efficacy of mitomycin C irrigation after removal of an occluded nasolacrimal stent.[J].2007,18(4).
- [11].Species-specific characteristics of the biofilm generated in silicone tube: an in vitro study.[J].2018,18(1).
- [12]Park, Ju Young,Lee, Jung Bok,Shin, Woo Beom,etc.Nasolacrimal stent with shape memory as an advanced alternative to silicone products[J].2020,101.
- [13]A, Ibá?ez,A, Trinidad,J R, García-Berrocal,etc.Biofilm colonisation in nasolacrimal stents.[J].2011,7(1).
- [14]Ali, Mohammad Javed,Paulsen, Friedrich.Prolactin and Prolactin-inducible protein (PIP) in the pathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)[J].2019,125.
- [15]Schaudig U.,Maas R..The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications[J].2000,238(9).
- [16]Dogan,R.,Meric,A.,Ozsütcü,M.,etc.Diode laser-assisted endoscopic dacryocystorhinostomy: A comparison of three different combinations of adjunctive procedures[J].2013,270(8).
- [17]SAURABH KAMAL.Clinical Significance of Microbial Growth on the Surfaces of Silicone Tubes Removed From Dacryocystorhinostomy Patients[J].2012,153(1).
- [18]Chaloupka, K.,Motwani, M.,Seifalian, A.M..Development of a new lacrimal drainage conduit using POSS nanocomposite[J].2011,58(Pt.5).
- [19]Zexian,Xu,Jiachang,Jin,Lei,Hou,etc.[Fabrication of hydrophilic medical catheter with hydrogel grafting and the in vivo evaluation of its histo-compatibility].[J].2019,36(2).
- [20]Jeong Heon, Lee,Mi Sun, Kang,Jae Wook, Yang.Clinicopathologic findings after nasolacrimal polyurethane stent implantations.[J].2005,19(4).